A new study has found that the diabetes drug tirzepatide helps people lower their blood sugar and lose weight more quickly ...

In a world inundated with weight loss products and miracle supplements, it can be overwhelming to determine what truly works. Enter LipoVive, a groundbreaking supplement that has captured the ...

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra’s obesity drug. AI takes center stage at HIMSS ...

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

It mimics two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). When you eat, ...

Tirzepatide (Mounjaro) also affects the glucose-dependent insulinotropic polypeptide (GIP) hormone, which controls metabolism and helps regulate energy balance. The first study into weight-loss ...

It has been established that when food is consumed, the body releases hormones called incretins to help regulate blood sugar, appetite and energy use. Two important incretins, GLP-1 and GIP ...

LipoVive leverages a blend of natural ingredients known for their effects on key hormones, namely GLP-1 and GIP, which are essential for controlling hunger and blood sugar levels. The product is ...

while Eli Lilly's own drug Zepbound targets both GLP-1 and another hormone called GIP. Some drugmakers believe that targeting amylin could reduce the gastrointestinal side effects typically seen ...